Max Smock
Stock Analyst at William Blair
(1.06)
# 3,568
Out of 4,734 analysts
16
Total ratings
33.33%
Success rate
-6.62%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Max Smock
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICLR ICON Public Limited Company | Reiterates: Outperform | n/a | $198.11 | - | 1 | Jan 14, 2025 | |
| CRL Charles River Laboratories International | Reiterates: Outperform | n/a | $163.50 | - | 1 | Jan 14, 2025 | |
| FTRE Fortrea Holdings | Reiterates: Market Perform | n/a | $17.69 | - | 4 | Nov 8, 2024 | |
| CDMO Avid Bioservices | Reiterates: Market Perform | n/a | $12.39 | - | 3 | Nov 7, 2024 | |
| SLP Simulations Plus | Reiterates: Outperform | n/a | $29.92 | - | 4 | Nov 6, 2024 | |
| MEDP Medpace Holdings | Reiterates: Outperform | n/a | $337.35 | - | 3 | Oct 22, 2024 |
ICON Public Limited Company
Jan 14, 2025
Reiterates: Outperform
Price Target: n/a
Current: $198.11
Upside: -
Charles River Laboratories International
Jan 14, 2025
Reiterates: Outperform
Price Target: n/a
Current: $163.50
Upside: -
Fortrea Holdings
Nov 8, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $17.69
Upside: -
Avid Bioservices
Nov 7, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $12.39
Upside: -
Simulations Plus
Nov 6, 2024
Reiterates: Outperform
Price Target: n/a
Current: $29.92
Upside: -
Medpace Holdings
Oct 22, 2024
Reiterates: Outperform
Price Target: n/a
Current: $337.35
Upside: -